OPKO Health, Inc. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
OPKO Health, Inc. (OPK) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $18.07 million for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2026-08-28
- OPKO Health, Inc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2025-12-31 was $0.00.
- OPKO Health, Inc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2025-09-30 was $101.58M, a 16.39% decline year-over-year.
- OPKO Health, Inc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2024-12-31 was $0.00.
- OPKO Health, Inc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2024-09-30 was $121.49M.
- OPKO Health, Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2025 was $101.58M, a 16.39% decline from fiscal 2024.
- OPKO Health, Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2024 was $121.49M.
- OPKO Health, Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- OPKO Health, Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2022 was $18.56M.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.07M 10-Q/A · filed 2026-08-28 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $101.58M derived: sum of 2 quarters · filed 2026-02-26 | $101.58M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $101.58M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-10-29 | $101.58M 10-Q · filed 2025-10-29 | ||
| 2025-06-30 | $0.00 10-Q/A · filed 2026-08-28 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $121.49M derived: sum of 2 quarters · filed 2026-02-26 | $121.49M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $121.49M 10-Q · filed 2024-11-07 | $121.49M 10-Q · filed 2025-10-29 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2022-12-31 | $18.56M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |